Fairvalue-Calculator Fairvalue-Calculator
EN DE

Femasys Inc (FEMY) Fair Value & Analysis

Healthcare · US · Market cap $12.2M

Price$3.67
Fair Value$0.5300
Upside-85.6%
Quality95/100
Evidence: Low Range $0.3500 – $0.6600

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Femasys Inc (FEMY) currently trades at $3.67, while our model-based Fair Value estimate is $0.5300 — implying the stock looks roughly 85.6% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -60% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -38% Medline Inc (MDLN) -16% Becton, Dickinson and Company (BDX) -26% Alcon Inc (ALC) -32%

Frequently asked questions

Is Femasys Inc (FEMY) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.5300 versus a price of $3.67 — about −86% (overvalued). Model-based estimate, not financial advice.
What is the fair value of FEMY?
Our 21-model fair value for Femasys Inc is $0.5300 (as of Jun 25, 2026), built from audited fundamentals. The current price is $3.67.
What is the quality score of FEMY?
Femasys Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.